Skip to main content
. 2018 Nov 8;18:172. doi: 10.1186/s12876-018-0901-0

Fig. 2.

Fig. 2

25(OH)D levels in CAAG patients having absence of ECL hyperplasia (ECL0), linear or micronodular ECL hyperplasia (ECL+) or gastric carcinoid (GC1)